Deutsche Bank raised the firm’s price target on Edwards Lifesciences (EW) to $94 from $85 and keeps a Buy rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Edwards Lifesciences: Strong Financial Performance and Strategic Advancements Drive Buy Rating
- Edwards Lifesciences price target raised to $90 from $83 at Piper Sandler
- Edwards Lifesciences Announces Leadership Change in TAVR Division
- Strong Growth Potential for Edwards Lifesciences: Buy Rating Affirmed by Analyst Brandon Vazquez
- Edwards Lifesciences Reports Strong Q2 Growth